Exposure of rat hippocampal neurons to amyloid β peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417

Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor

Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,393

Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses

Arcaro, A., & Wymann, M. P. (1993) · Biochemical Journal · doi:10.1042/bj2960297 · Cited by 1,138

Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699

β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding

Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595

Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B

Welsh, G. I., & Proud, C. G. (1993) · Biochemical Journal · doi:10.1042/bj2940625 · Cited by 397

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 385

Isorhynchophylline Treatment Improves the Amyloid-β-Induced Cognitive Impairment in Rats via Inhibition of Neuronal Apoptosis and Tau Protein Hyperphosphorylation

Xian, Y., Mao, Q., Wu, J. C., Su, Z., Chen, J., Lai, X., Ip, S., & Lin, Z. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131457 · Cited by 84

GSK3β overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus

Sirerol‐Piquer, M., Gómez‐Ramos, P., Hernández, F., Pérez, M., Morán, M. A., Fuster-Matanzo, A., Lucas, J. J., Ávila, J., & García‐Verdugo, J. M. (2010) · Hippocampus · doi:10.1002/hipo.20805 · Cited by 83

Glycogen Synthase Kinase-3β Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase 3

Mishra, R., Barthwal, M. K., Sondarva, G. V., Rana, B., Wong, L., Chatterjee, M., Woodgett, J. R., & Rana, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705895200 · Cited by 78

Changes in the ageing brain in health and disease

Anderton, B. H. (1997) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1997.0162 · Cited by 82

Modulation of β-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors

Hellström‐Lindahl, E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00028-5 · Cited by 76

M1 muscarinic receptor activation protects neurons from β-amyloid toxicity. A role for Wnt signaling pathway

Farías, G. G., Godoy, J. A., Hernández, F., Avila, J., Fisher, A., & Inestrosa, N. C. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.016 · Cited by 59

Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms

Liu, G., Zhang, Y., Yao, X., Zhang, C., Fang, J., Wang, Q., & Wang, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.012 · Cited by 72

A molecular cell biology of lithium

Williams, R. S. B., Ryves, W. J., Dalton, E. C., Eickholt, B. J., Shaltiel, G., Agam, G., & Harwood, A. J. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320799 · Cited by 71

Targeting Glycogen Synthase Kinase‐3β for Therapeutic Benefit against Oxidative Stress in Alzheimer′s Disease: Involvement of the Nrf2‐ARE Pathway

Kanninen, K. M., White, A. R., Koıstınaho, J., & Malm, T. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/985085 · Cited by 70

Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease

Kumar, P., Jha, N. K., Jha, S. K., Ramani, K., & Ambasta, R. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140933 · Cited by 67

Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites

Su, J. H., Cummings, B. J., & Cotman, C. W. (1998) · Acta Neuropathologica · doi:10.1007/s004010050920 · Cited by 67

Effects of endogenous β‐amyloid overproduction on tau phosphorylation in cell culture

Wang, Z., Li, H., Li, X., Zhang, Q., Tian, Q., Wang, Q., Xu, H., & Wang, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03956.x · Cited by 65

Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing

Uddin, M. S., Kabir, M. T., Jeandet, P., Mathew, B., Ashraf, G. M., Perveen, A., Bin-Jumah, M. N., Mousa, S. A., & Abdel‐Daim, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7039138 · Cited by 67

What’s hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders

Westmark, C. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.122 · Cited by 63

Sex modulates the ApoE ε4 effect on brain tau deposition measured by 18F-AV-1451 PET in individuals with mild cognitive impairment

Liu, M., Paranjpe, M. D., Zhou, X., Duy, P. Q., Goyal, M. S., Benzinger, T. L. S., Lu, J., Wang, R., & Zhou, Y. (2019) · Theranostics · doi:10.7150/thno.35366 · Cited by 67

Discovery of Novel GSK-3β Inhibitors with Potent in Vitro and in Vivo Activities and Excellent Brain Permeability Using Combined Ligand- and Structure-Based Virtual Screening

Khanfar, M. A., Hill, R. A., Kaddoumi, A., & Sayed, K. A. E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100941j · Cited by 63

Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease

Qu, L., Li, S., Ji, L., Luo, S., Ding, M., Yin, F., Wang, C., Luo, H., Lu, D., Liu, X., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113889 · Cited by 61

Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes

Cheng, H., Gang, X., Liu, Y., Wang, G., Zhao, X., & Wang, G. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2019 · Cited by 63

Glycogen Synthase Kinase-3 in Neurodegeneration and Neuroprotection:Lessons from Lithium

Aghdam, S. Y., & Barger, S. W. (2007) · Current Alzheimer Research · doi:10.2174/156720507779939832 · Cited by 61

Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons

Huang, H., Ou, H., & Hsieh, S. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00511-7 · Cited by 61

PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8

Okuda, M., Fujita, Y., Hijikuro, I., Wada, M., Uemura, T., Kobayashi, Y., Waku, T., Tanaka, N., Nishimoto, T., Izumi, Y., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161017 · Cited by 59

Protective effects of erythropoietin on tau phosphorylation induced by β‐amyloid

Sun, Z., Yang, H., Pan, J., Zhen, H., Wang, Z., Chen, S., & Ding, J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21745 · Cited by 58

A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease

Modi, K. K., Jana, A., Ghosh, S., Watson, R. L., & Pahan, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103606 · Cited by 55

Glycogen Synthase Kinase-3 Modulates Neurite Outgrowth in Cultured Neurons: Possible Implications for Neurite Pathology in Alzheimer's Disease

Muñoz-Montaño, J. R., Lim, F., Moreno, F. J., Ávila, J., & Díaz‐Nido, J. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-1602 · Cited by 55

Tau acts as a mediator forAlzheimer's disease‐related synaptic deficits

Liao, D., Miller, E. C., & Teravskis, P. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12504 · Cited by 53

The marine natural-derived inhibitors of glycogen synthase kinase-3β phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling

Khanfar, M. A., Abuasal, B., Mudit, M., Kaddoumi, A., & Sayed, K. A. E. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.054 · Cited by 53

Cytoskeletal mechanisms of neuronal degeneration

Brandt, R. (2001) · Cell and Tissue Research · doi:10.1007/s004410000334 · Cited by 52

Hypoxia-induced mitochondrial and nuclear DNA damage in the rat brain

Englander, E. W., Greeley, G. H., Wang, G., Perez-Polo, J. R., & Lee, H.-M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991015)58:2 · Cited by 51

Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons

Zhang, Z., Zhao, R., Qi, J., Wen, S., Tang, Y., & Wang, D. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22563 · Cited by 48

Common Pathological Processes and Transcriptional Pathways in Alzheimer's Disease and Type 2 Diabetes

Jones, A., Kulozik, P., Ostertag, A., & Herzig, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0973 · Cited by 47

Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src

Yao, X., Zhang, X., Yin, Y., Liu, B., Luo, D., Liu, D., Chen, N., Ni, Z.-F., Wang, X., Wang, Q., et al. (2011) · Biochemical Journal · doi:10.1042/bj20110347 · Cited by 47

Dieckol Ameliorates Aβ Production via PI3K/Akt/GSK-3β Regulated APP Processing in SweAPP N2a Cell

Yoon, J.-H., Lee, N., Youn, K., Jo, M. R., Kim, H., Lee, D., Ho, C., & Jun, M. (2021) · Marine Drugs · doi:10.3390/md19030152 · Cited by 46

The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.

Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43

Oxidative Stress-Induced Damage to the Developing Hippocampus Is Mediated by GSK3β

Abbah, J., Vacher, C., Goldstein, E. Z., Li, Z., Kundu, S., Talbot, B., Bhattacharya, S., Hashimoto‐Torii, K., Wang, L., Banerjee, P., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2389-21.2022 · Cited by 46

Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer’s Disease

Henriques, A. G., Oliveira, J. M., Carvalho, L., & Silva, O. A. B. D. C. E. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8913-4 · Cited by 45

Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice

Fan, L., Qiu, X., Zhu, Z., Lv, J., Lu, J., Mao, F., Zhu, J., Wang, J., Guan, X., Chen, J., et al. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0220-1 · Cited by 46

Alzheimer's disease: relationship between muscarinic cholinergic receptors, β‐amyloid and tau proteins

Pavı́a, J., CEBALLOS, M. L. D., & de la Cuesta, F. S. (1998) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1998.tb00975.x · Cited by 44

Phosphatidylinositol-3-kinase activation blocks amyloid beta-induced neurotoxicity

Lee, K., Koh, S., Noh, M., Kim, S. H., & Lee, Y. J. (2007) · Toxicology · doi:10.1016/j.tox.2007.09.020 · Cited by 44

Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer’s Disease

Leung, H.-W., Foo, G., & VanDongen, A. M. J. (2022) · Biomedicines · doi:10.3390/biomedicines10081946 · Cited by 41

The inhibition of glycogen synthase kinase 3β by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Aβ peptides

Liu, F., Gong, X., Zhang, G., Marquis, K. L., Reinhart, P. H., & Andree, T. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03474.x · Cited by 42

Possible Role of the Glycogen Synthase Kinase-3 Signaling Pathway in Trimethyltin-Induced Hippocampal Neurodegeneration in Mice

Kim, J., Yang, M., Kim, S.-H., Kim, J. C., Wang, H., Shin, T., & Moon, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070356 · Cited by 39

Correction: A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease

Modi, K. K., Jana, A., Ghosh, S., Watson, R. L., & Pahan, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180602 · Cited by 39

GSK-3β and memory formation

Takashima, A. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00047 · Cited by 39

Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications

Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 40

Intranasal insulin and orexins to treat age-related cognitive decline

Erichsen, J. M., Calva, C. B., Reagan, L. P., & Fadel, J. R. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113370 · Cited by 38

Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders

Birajdar, S. V., Mazahir, F., Alam, M. I., Kumar, A., & Yadav, A. K. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176117 · Cited by 37

Glycogen Synthase Kinase 3β-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2

Yagishita, S., Murayama, M., Ebihara海老原朋江, T., Maruyama丸山敬, K., & 高島, 明. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.619668 · Cited by 35

NUB1 modulation of GSK3β reduces tau aggregation

Richet, E., Pooler, A. M., Rodriguez, T., Novoselov, S. S., Schmidtke, G., Groettrup, M., Hanger, D. P., Cheetham, M. E., & van der Spuy, J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds376 · Cited by 35

Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Role of GSK-3β in Adult Brain

Takashima, A. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r29fm · Cited by 34

Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth

Yuan, Q., Liu, J., He, J. H., Huang, L., Dou, L., & Wu, S. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.133137 · Cited by 34

Recruitment of active glycogen synthase kinase-3 into neuronal lipid rafts

Sui, Z., Kovács, A., & Maggirwar, S. B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.087 · Cited by 35

Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)

Salemi, J., Obregon, D. F., Cobb, A., Reed, S., Sadic, E., Jin, J., Fernandez, F., Tan, J., & Giunta, B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-3 · Cited by 28

Stress proteins in Alzheimer's disease

Smith, R. C., Rosen, K. M., Pola, R., & Magrané, J. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500133165 · Cited by 33

Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease

Savage, M. J., & Gingrich, D. E. (2009) · Drug Development Research · doi:10.1002/ddr.20287 · Cited by 33

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy

Ahn, E. H., & Park, J. (2025) · Cells · doi:10.3390/cells14020089 · Cited by 37

δ‐Catenin/NPRAP: A new member of the glycogen synthase kinase‐3β signaling complex that promotes β‐catenin turnover in neurons

Bareiss, S. K., Kim, K., & Lu, Q. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22414 · Cited by 32

Administration of Momordica charantia Enhances the Neuroprotection and Reduces the Side Effects of LiCl in the Treatment of Alzheimer’s Disease

Huang, H.-J., Chen, S.-L., Chang, Y.-T., Chyuan, J., & Hsieh‐Li, H. M. (2018) · Nutrients · doi:10.3390/nu10121888 · Cited by 31

Enhancement of insulin‐induced PI3K/Akt/GSK‐3β and ERK signaling by neuronal nicotinic receptor/PKC‐α/ERK pathway: up‐regulation of IRS‐1/‐2 mRNA and protein in adrenal chromaffin cells

Sugano, T., Yanagita, T., Yokoo, H., Satoh, S., Kobayashi, H., & Wada, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03846.x · Cited by 32

Dissecting Endoplasmic Reticulum Unfolded Protein Response (UPRER) in Managing Clandestine Modus Operandi of Alzheimer’s Disease

Rahman, S., Ayyagari, A., Jan, A. T., & Minakshi, R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00030 · Cited by 33

Inactivation of glycogen synthase kinase-3β protects against kainic acid-induced neurotoxicity in vivo

Goodenough, S., Conrad, S., Skutella, T., & Behl, C. (2004) · Brain Research · doi:10.1016/j.brainres.2004.08.021 · Cited by 31

Aβ inhibits SREBP-2 activation through Akt inhibition

Mohamed, A., Viveiros, A., Williams, K., & Chaves, E. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m076703 · Cited by 35

The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer’s Disease In Vitro

Mavroidi, B., Kaminari, A., Matiadis, D., Hadjipavlou‐Litina, D., Pelecanou, M., Tzinia, A. K., & Sagnou, M. (2022) · Brain Sciences · doi:10.3390/brainsci12060806 · Cited by 30

Growth factor treatment to overcome Alzheimer's dysfunctional signaling

Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.018 · Cited by 30

Amyloid beta1-42 peptide regulates microtubule stability independently of tau

Pianu, B., Lefort, R., Thuiliere, L., Tabourier, E., & Bartolini, F. (2014) · Journal of Cell Science · doi:10.1242/jcs.143750 · Cited by 30

Overexpression of GSK3βS9A Resulted in Tau Hyperphosphorylation and Morphology Reminiscent of Pretangle-Like Neurons in the Brain of PDGSK3β Transgenic Mice

Li, B., Ryder, J. W., Yuan, S., Moore, S. A., Jr., Liu, F., Solenberg, P. J., Brune, K. A., Fox, N. W., Ni, B., Liu, R., et al. (2004) · Transgenic Research · doi:10.1023/b:trag.0000040039.44899.6f · Cited by 28

Bridging the Gap between Alzheimer’s Disease and Alzheimer’s-like Diseases in Animals

Gołaszewska, A., Bik, W., Motyl, T., & Orzechowski, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071664 · Cited by 31

Exploring the phytochemistry, pharmacognostic properties, and pharmacological activities of medically important plant Momordica Charantia

Mukherjee, S., & Karati, D. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100226 · Cited by 27

The γ-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer’s Disease

Lanzillotta, A., Sarnico, I., Benarese, M., Branca, C., Baiguera, C., Hutter‐Paier, B., Windisch, M., Spano, P., Imbimbo, B. P., & Pizzi, M. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9482-2 · Cited by 27

The contribution of C. elegans neurogenetics to understanding neurodegenerative diseases

Liang, J., McKinnon, I. A., & Rankin, C. H. (2020) · Journal of Neurogenetics · doi:10.1080/01677063.2020.1803302 · Cited by 28

The Tyr216 phosphorylated form of GSK3β contributes to tau phosphorylation at PHF-1 epitope in response to Aβ in the nucleus of SH-SY5Y cells

Noël, A., Barrier, L., & Ingrand, S. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.020 · Cited by 24

Diabetes, Insulin and Alzheimer's Disease

Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24

Silencing I2PP2A Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice

Zhang, Y., Ma, R.-H., Li, X., Zhang, J.-Y., Shi, H.-R., Wei, W., Luo, D., Wang, Q., Wang, J., & Liu, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00123 · Cited by 23

16-Hydroxycleroda-3,13-dien-15,16-olide deregulates PI3K and Aurora B activities that involve in cancer cell apoptosis

Lin, Y., Lee, C.-C., Chan, W.-L., Chang, W., Wu, Y., & Chang, J. (2011) · Toxicology · doi:10.1016/j.tox.2011.04.004 · Cited by 23

Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease

Eremin, D. V., Kondaurova, E. M., Rodnyy, A. Y., Molobekova, C. A., Kudlay, D. A., & Naumenko, V. S. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923120064 · Cited by 23

Amyloid Beta Peptide Impaired Carbachol but not Glutamate-Mediated Phosphoinositide Pathways in Cultured Rat Cortical Neurons

Huang, H., Ou, H., & Hsieh, S. (2000) · Neurochemical Research · doi:10.1023/a:1007592007956 · Cited by 21

Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer’s Disease

Teixeira, C. M., Pallas‐Bazarra, N., Bolós, M., Terreros‐Roncal, J., Ávila, J., & Llorens-Martı́n, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179918 · Cited by 20

Pathophysiological concentrations of amyloid β proteins directly inhibit rat brain and recombinant human type II phosphatidylinositol 4‐kinase activity

Wu, B., Kitagawa, K., Zhang, N., Liu, B., & Inagaki, C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02805.x · Cited by 20

Discovery of effective GSK-3β inhibitors as therapeutic potential against Alzheimer's disease: A computational drug design insight

Asl, F. S. S., Malverdi, N., Mojahedian, F., Baziyar, P., & Nabi‐Afjadi, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141273 · Cited by 19

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models

Zou, Y., Gan, C., Xin, Z., Zhang, H., Zhang, Q., Lee, T. H., Pan, X., & Chen, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.769229 · Cited by 19

Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain

Spears, W. E., Furgerson, M., Sweetnam, J. M. C., Evans, P. T., Gearing, M., Fechheimer, M., & Furukawa, R. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-74 · Cited by 19

Amyloid-Beta Induced CA1 Pyramidal Cell Loss in Young Adult Rats Is Alleviated by Systemic Treatment with FGL, a Neural Cell Adhesion Molecule-Derived Mimetic Peptide

Corbett, N. J., Gabbott, P. L. A., Klementiev, B., Davies, H. A., Colyer, F. M., Novikova, T., & Stewart, M. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071479 · Cited by 19

Aβ Deposition Does Not Cause the Aggregation of Endogenous Tau in Transgenic Mice

Xu, G. M., Gonzales, V., & Borchelt, D. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200207000-00011 · Cited by 19

Amyloid β peptide enhanced bradykinin-mediated inositol (1,4,5)trisphosphate formation and cytosolic free calcium

Huang, H., Ou, H., & Hsueh, S.-J. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00260-4 · Cited by 19

Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg‐ArcSwe Mice and Alzheimer′s Disease Brain

Blom, E. S., Wang, Y., Skoglund, L., Hansson, A. C., Ubaldi, M., Lourdusamy, A., Sommer, W. H., Mielke, M. L., Hyman, B. T., Heilig, M. A., et al. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/936580 · Cited by 18

Modulating Metals As A Therapeutic Strategy For Alzheimer’s Disease

Hung, L. W., & Barnham, K. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.32 · Cited by 18

Effect of arctigenin on neurological diseases: A review

Li, M., Jiang, H., Wang, Y., Xu, Z., Xu, H., Chen, Y., Zhu, J., Lin, Z., & Zhang, M. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116642 · Cited by 17

Parkin Attenuates Wild-Type τ Modification in the Presence of β-Amyloid and α-Synuclein

Moussa, C. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9099-x · Cited by 17

SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease

Wu, X., Kosaraju, J., Zhou, W., & Tam, K. Y. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.003 · Cited by 16

Synthetic, Cell-Derived, Brain-Derived, and Recombinant β-Amyloid: Modelling Alzheimer’s Disease for Research and Drug Development

Varshavskaya, K. B., Mitkevich, V. A., Makarov, A. А., & Barykin, E. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315036 · Cited by 18

Gene expression profile in β-amyloid-treated SH-SY5Y neuroblastoma cells

Martínez, T., & Pascual, A. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.01.010 · Cited by 15

Amyloid β-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)

Kubo, T., Nishimura, S., & Oda, T. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00416-3 · Cited by 14

A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease

Khan, R. I., Nirzhor, S. S. R., & Rashid, B. (2018) · Brain Sciences · doi:10.3390/brainsci8090162 · Cited by 12

Oat Extract Avenanthramide-C Reverses Hippocampal Long-Term Potentiation Decline in Tg2576 Mice

Lee, Y., Wang, M., Son, Y., Yang, E. J., Kang, M.-S., Kim, H., Kim, H., & Jo, J. (2021) · Molecules · doi:10.3390/molecules26206105 · Cited by 12

Multifunctional Role of Fas-Associated Death Domain Protein in Apoptosis

Kim, K. (2002) · BMB Reports · doi:10.5483/bmbrep.2002.35.1.001 · Cited by 13

Parkin Attenuates Wild-Type τ Modification in the Presence of β-Amyloid and α-Synuclein

Moussa, C. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9167-2 · Cited by 11

GSK-3β orchestrates the inhibitory innervation of adult-born dentate granule cells in vivo

Moreno-Jiménez, E. P., Flor-García, M., Hernández-Vivanco, A., Terreros-Roncal, J., Rodríguez-Moreno, C. B., Toni, N., Mendez, P., & Llorens-Martín, M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04874-w · Cited by 10

Huperzine A Regulates the Physiological Homeostasis of Amyloid Precursor Protein Proteolysis and Tau Protein Conformation—A Computational and Experimental Investigation

Wongjaikam, S., Nopparat, C., Boontem, P., Panmanee, J., Thasana, N., Shukla, M., & Govitrapong, P. (2024) · Biology · doi:10.3390/biology13070518 · Cited by 10

Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3β

Engel, T., Goñi‐Oliver, P., Gómez‐Ramos, P., Morán, M. A., Lucas, J. J., Ávila, J., & Hernández, F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.047 · Cited by 10

Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid β peptide (25–35) enhances phosphorylation of tau in hippocampal neurons

Takashima, A., Honda, T., Yasutake, K., Michel, G., Murayama, O., Murayama, M., Ishiguro, K., & Yamaguchi, H. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00061-3 · Cited by 287

Amyloid β peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3β in rat hippocampal neurons

Takashima, A., Yamaguchi, H., Noguchi, K., Michel, G., Ishiguro, K., Sato, K., Hoshino, T., Hoshi, M. M., & Imahori, K. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11964-x · Cited by 54

Physiologic Levels of β‐Amyloid Activate Phosphatidylinositol 3‐Kinase with the Involvement of Tyrosine Phosphorylation

Luo, Y., Sunderland, T., & Wolozin, B. L. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67030978.x · Cited by 39

[Involvement of tau protein kinase in amyloid-beta-induced neurodegeneration].

Ishiguro, K. (1998) · PubMed · Cited by 6

β-Amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3β, and PTEN

Nassif, M., Hoppe, J. B., Santin, K., Frozza, R. L., Zamin, L. L., Simão, F., Horn, A. P., & Salbego, C. G. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.008 · Cited by 52